Concepedia

Aimée Dallob

AD

25

Publications

1.7K

Citations

21

H-Index

1979

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Oxford

Thomas Jefferson University

Merck Canada Inc. (Canada)

United States Military Academy

Aimée Dallob is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1979–2015

25

Publications

25

Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers

Anne Van Hecken, Jules I. Schwartz, Marleen Depré et al. · The Journal of Clinical Pharmacology · 2000 · 355 citations

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors

Christine Brideau, Stacia Kargman, S. Liu et al. · Inflammation Research · 1996 · 281 citations

, , +15

The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia

Lynn A. Drake, Maria Hordinsky, Virginia C. Fiedler et al. · Journal of the American Academy of Dermatology · 1999 · 182 citations

, , +5

Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort

Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck et al. · Journal of Alzheimer s Disease · 2015 · 97 citations

Characterization of Etoricoxib, a Novel, Selective COX‐2 Inhibitor

Aimée Dallob, Christopher J. Hawkey, Howard Greenberg et al. · The Journal of Clinical Pharmacology · 2003 · 91 citations

Rows per page

1–5 of 25